课题基金 / 基金详情

OCULAR MANIFESTATIONS OF THE ACQUIRED IMMUNE DEFICIENCY SYNDROME

OCULAR MANIFESTATIONS OF THE ACQUIRED IMMUNE DEFICIENCY SYNDROME
获得性免疫缺陷综合征的眼部表现
批准号:
5202321
负责人:
M D DE SMET
金额:
$0.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至

项目摘要

项目成果

M D DE SMET的其他基金

相似基金

相关文献

中文摘要
翻译
患有后天免疫缺陷综合症(艾滋病)的患者是 有发展为严重眼部问题的风险, 人类免疫缺陷病毒(HIV)或 机会性感染其中一些问题可能导致失明 如果不治疗的话。在许多病原体中, 失明,巨细胞病毒(CMV)是迄今为止最常见的。 在1995财政年度,我们完成了对更昔洛韦的分析, 植入这个装置在眼睛里缓慢释放抗病毒药物 CMV视网膜炎这是一个有效的手段,阻止进展 长达八个月的疾病,而不会引起任何显着的 并发症患者生存率与 最佳的全身治疗,但患者有更好的质量, 生活
英文摘要
Patients suffering from acquired immunodeficiency syndrome (AIDS) are at risk for developing significant ocular problems either as a direct result of the human imunodeficiency virus (HIV) or as a result of opportunistic infections. Some of these problems can lead to blindness if left untreated. Among the many pathogens that can lead to blindness, cytomegalovirus (CMV) is by far the most common. In fiscal year 1995, we completed our analysis of the ganciclovir implant. This device slowly releases antiviral medication in an eye with CMV retinitis. It is an effective means of arresting progression of disease for up to eight months without inducing any significant complication. Patient survival is moderately reduced as compared with optimal systemic therapy, but patients have a much better quality of life.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CHARACTERIZATION OF IMMUNE RESPONSES TO S-ANTIGEN
  • 批准号:
    3841240
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    M D DE SMET
  • 依托单位:
MODULATION OF IMMUNE FUNCTIONS USING THE IMMUNOTOXIN IL2-PE40
  • 批准号:
    3877082
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    M D DE SMET
  • 依托单位:
OCULAR MANIFESTATIONS OF THE ACQUIRED IMMUNE DEFICIENCY SYNDROME
  • 批准号:
    3841221
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    M D DE SMET
  • 依托单位:
CHARACTERIZATION OF IMMUNE RESPONSES TO S-ANTIGEN
  • 批准号:
    3856064
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    M D DE SMET
  • 依托单位:
海外基金